Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

1.66
Delayed Data
As of 2:12pm ET
 +0.0352 / +2.17%
Today’s Change
1.20
Today|||52-Week Range
22.64
-68.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization95.0K25.0K45.0K160.0K
 
 
 
 
 
 
Operating ExpensesGross Income-95.0K-25.0K-45.0K-160.0K
 
 
 
 
 
General Expenses16.5M14.6M10.7M8.5M
 
 
 
 
 
Research And Development14.1M10.8M7.8M7.0M
 
 
 
 
 
Total Operating Expenses16.6M14.6M10.7M8.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.6M-14.6M-10.7M-8.7M
 
 
 
 
 
Extraordinary Credit169.0K1.6M0.009.0M
 
 
 
 
Extraordinary Charge0.000.00-600.0K0.00
 
 
Other Expenses-47.0K19.0K97.0K-28.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-16.5M-13.0M-11.2M313.0K
 
 
 
 
 
Preferred Dividend-8.8M-2.1M-2.5M0.00
 
 
 
 
Net Income-16.5M-13.0M-11.2M313.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.2M5.3M6.8M10.1M
 
 
 
 
 
Shares To Calculate EPS Diluted5.2M5.3M6.8M10.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.88-$2.88-$16.24$0.03
 
 
 
 
 
EPS Diluted-$4.88-$2.88-$2.03$0.03